Medicare Program Integrity Manual (Pub. 100-08), Ch. 10 § 10.2.5.2

Fraud Level Indicators for DMEPOS Suppliers - Development and

Last amended: 2022Year: 2022Length: 917 wordsOfficial source
10.2.5.2 – Fraud Level Indicators for DMEPOS Suppliers - Development and Use (Rev. 11682; Issued: 11-04-2022; Effective: 12-05-2022; Implementation: 12-05-2022) A. General Information The contractor shall perform a fraud potential analysis of all DMEPOS applicants and current DMEPOS suppliers. The fraud level indicator shall represent the potential for fraud and/or abuse. The contractor shall use four fraud level indicator codes as follows: • Low Risk (e.g., national drug store chains) • Limited Risk (e.g., prosthetist in a low fraud area) • Medium Risk (e.g., midsize general medical supplier in a high fraud area) • High Risk (e.g., very small space diabetic supplier with low inventory in a high fraud area whose owner has previously had a chapter 7 bankruptcy). High fraud areas shall be determined by contractor analysis with concurrence of the contractor project officer. (NOTE: These risk categories are in addition to, and not in lieu of, those specified in 42 CFR § 424.518.) In assessing a fraud level indicator, the contractor shall consider such factors as: • Experience as a DMEPOS supplier with other payers • Prior Medicare experience • The geographic area • Fraud potential of products and services listed • Site visit results • Inventory observed and contracted • Accreditation of the supplier After a fraud level indicator is assigned and the DMEPOS supplier is enrolled, the contractor shall establish a DMEPOS Review Plan based on the fraud level assessment. The DMEPOS Review Plan shall contain information regarding: • Frequency of unscheduled site visits • Maximum billing amounts before recommendation for prepay medical review • Maximum billing spike amounts before recommendation for payment suspensions/prepay medical review, etc. The fraud level indicator shall be updated based upon information obtained through the Medicare enrollment process, such as reported changes of information. Information obtained by the Office of Inspector General (OIG), CMS (including CMS satellite office), and/or a Unified Program Integrity Contractor (UPIC) shall be reported to the contractor project officer. The contractor shall update the fraud level indicator based on information obtained by the OIG, CMS (including CMS satellite office), and/or a UPIC only after the review and concurrence of the contractor project officer. In addition, the contractor shall monitor and assess geographic trends that indicate or demonstrate that one geographic area has a higher potential for having fraudulent suppliers. B. When a DMEPOS Fraud Level Indicator Differs from Risk Screening Category under 42 CFR § 424.518 The fraud level indicator described in this subsection is unrelated to the risk screening categories required under 42 CFR § 424.518. Under § 424.518(c)(1)(ii), for example, newly enrolling DMEPOS suppliers are assigned to the “high” risk screening category. Such DMEPOS suppliers are therefore subject to screening activities that correspond to the “high” risk screening category, including an on-site visit and a fingerprint-based criminal background check for all individuals who maintain a 5 percent or greater direct or indirect ownership interest in the supplier. (See § 424.518(c)(2).) The on-site visits that the contractor conducts are responsive to the requirement at § 424.518(c)(2)(i) for a site visit and include gathering information concerning fraud level indicator assignment as required in this subsection. A DMEPOS supplier therefore has both a risk-based screening category assignment pursuant to requirements under § 424.518, and a separate fraud level indicator based upon the guidance in this subsection. C. Fraud Level Indicator Standards The contractor shall have documented evidence that it has, at a minimum, met the following requirements: • Assigned an appropriate fraud level indicator for at least 95 percent of all DMEPOS suppliers upon initial enrollment or revalidation. The fraud level indicator shall accurately reflect the risk the supplier poses to the Medicare program based on pre-defined criteria above. • Updated the DMEPOS fraud level indicator for each enrolled DMEPOS supplier on an annual basis. D. Alert Codes for DMEPOS Suppliers The contractor shall receive and maintain the following “alert indicators” from the DME MACs and UPICs: Alert Code and Definition A - Possible fraudulent or abusive claims identified B - Overpayments D - Violations of disclosure of ownership requirements E - Violations of participation agreements L - Suspended by contractor outside alert code process M - Supplier is going through claims appeal process The contractor shall append the supplier file and transfer to the DME-MACs and/or UPICs the following alert codes in the following circumstances: Alert Code and Definition C - Violations of supplier standards F - Excluded by the OIG or debarred per the System for Award Management H - Meets supplier standards; however, the contractor recommends increased scrutiny by the contractor (initiated by the contractor only) N - Supplier being investigated under the "Do Not Forward" initiative (initiated by contractor only) Q - Low Risk Fraud Level Indicator R - Limited Risk Fraud Level Indicator S - Medium Risk Fraud Level Indicator T - High Risk Fraud Level Indicator The contractor shall append an Alert Code "H" for any supplier that meets present supplier standards but appears suspect in one of the areas that are verified by the contractor. This alert code notifies the contractors that a supplier may be inclined to submit a high percentage of questionable claims. The contractor shall share the above information with the DME MACs and/or UPICs by sending alerts within 7 calendar days after identification of a supplier having common ownership or business ties with a sanctioned or suspect supplier for their research and/or action. The contractor also shall forward alert codes submitted by the contractors with the other contractors within 7 calendar days after receipt.
Medicare Program Integrity Manual (Pub. 100-08), Ch. 10 § 10.2.5.2: Fraud Level Indicators for DMEPOS Suppliers - Development and | Justis AI